Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis

Journal of the American Society of Nephrology

Volumn 11, Issue 4, 2000, Pages 717-728

  Combet, Sophie ^a,b   Miyata, Toshio ^c   Moulin, Pierre ^a   Pouthier, Dominique ^e   Coffin, Eric ^a   Devuyst, Olivier ^a,d  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b CEA SACLAY   (France)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ADVANCED GLYCATION END PRODUCT; CITRULLINE; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTOSIDINE; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAFILTRATION; UREMIA;

EID: 0034105056     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Korbet SM, Rodby RA: Peritoneal membrane failure: Differential diagnosis, evaluation, and treatment. Semin Dial 7: 128-137, 1994
2. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI: What really happens to people on long-term peritoneal dialysis? Kidney Int 54: 2207-2217, 1998
3. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Arisz L: Peritoneal transport characteristics of water, low-molecular weight solutes and proteins during long-term continuous ambulatory peritoneal dialysis. Perit Dial Bull 6: 61-65, 1986
4. Struijk DG, Krediet RT, Koomen GCM, Hoek FJ, Boeschoten EW, van der Reijden HJ, Arisz L: Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 59: 213-220, 1991
5. Selgas R, Fernandez-Reyes MJ, Bosque E, Bajo MA, Borrego F, Jimenez C, Del Peso G, De Alvaro F: Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective median long-term study. Am J Kidney Dis 23: 64-73, 1994
6. Davies SJ, Bryan J, Philips L, Russel GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11: 448-506, 1996
7. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9: 1285-1292, 1998
8. Shigamatau T: Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int 52[Suppl 62]: S105-S107, 1997
9. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Hoek FJ, Arisz L: A prospective study of peritoneal transport in CAPD patients. Kidney Int 45: 1739-1744, 1994
10. Krediet RT: Prevention and treatment of peritoneal dialysis membrane failure. Adv Ren Replace Ther 5: 212-217, 1998
11. Kubes P: Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 2: 235-244, 1995
12. Kone BC: Nitric oxide in renal health and disease. Am J Kidney Dis 30: 311-333, 1997
13. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC: Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997
14. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998
15. Nathan C, Xie QW: Nitric oxide synthases: Roles, tolls, and controls. Cell 78: 915-918, 1994
16. Devuyst O, Nielsen S, Cosyns J-P, Smith BL, Agre P, Squifflet J-P, Pouthier D, Goffin E: Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 275: H234-H242, 1998
17. Combet S, van Landschoot M, Moulin P, Piech A, Verbavatz J-M, Goffin E, Balligand J-L, Lameire N, Devuyst O: Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 10: 2185-2196, 1999
18. Douma CE, de Waart DR, Zemel D, Imholz ALT, Struijk DG, Krediet RT: Nitrate in stable CAPD patients and during peritonitis. Adv Perit Dial 11: 36-40, 1995
19. Yang CW, Hwang TL, Wu CH, Wu MS, Lai PC, Huang JY, Yu CC, Shyr MH, Huang CC: Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 11: 2466-2471, 1996
20. Nolph KD, Ghods A, Brown PA, Miller F, Harris PD, Pyle K, Popovich R: Effects of nitroprusside on peritoneal mass transfer coefficients and microvascular physiology. ASAIO Trans 23: 210-218, 1977
21. Douma CE, de Waart DR, Struijk DG, Krediet RT: The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 51: 1885-1892, 1997
22. Rippe B, Krediet RT: Peritoneal physiology: Transport of solutes. In: The Textbook of Peritoneal Dialysis, edited by Gokal R, Nolph KD, Dordrecht, The Netherlands, Kluwer Academic Publishers, 1994, pp 69-113
23. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990
24. vanderVliet A, Eiserich JP, Halliwell B, Cross CE: Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 272: 7617-7625, 1997
25. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991
26. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersele de Strihou C, Monnier VM, Witzum JL, Kurokawa K: Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J Clin Invest 100: 2995-3004, 1997
27. Schoell WM, Pieber D, Reich O, Lahousen M, Janicek M, Guecer F, Winter R: Tumor angiogenesis as a prognostic factor in ovarian carcinoma: Quantification of endothelial immunoreactivity by image analysis. Cancer 80: 2257-2262, 1997
28. Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients in end-stage renal falure: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7: 1198-1206, 1996
29. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM: Identification of pentosidine as a native structure for advanced glycation end products in β2-microglobulin forming amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA 93: 2353-2358, 1996
30. Devuyst O, Combet S, Pouthier D, Miyata T, Balligand JL, Goffin E: Enhanced production of nitric oxide (NO) and expression of endothelial NO synthase in human peritoneum exposed to long-term peritoneal dialysis [Abstract]. J Am Soc Nephrol 9: 191A, 1998
31. Simpson JF, Ahn C, Battifora H, Esteban JM: Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 77: 2077-2085, 1996
32. Miyata T, Wada T, Ahkand AA, Inagi R, Saito A, Devuyst O, Nakashima I, Kurokawa K: Carbonyl stress in CAPD peritoneum modifies endothelial and mesothelial cell surface proteins for activating vascular endothelial growth factor (VEGF) expression and intracellular protein-tyrosine phosphorylation [Abstract]. J Am Soc Nephrol 9: 286A, 1998
33. Krediet RT: The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 55: 341-356, 1999
34. Ho-Dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT: Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 17: 144-150, 1997
35. Mateijsen MAM, van der Wal AC, Hendriks PMEM, Zweers MM, Mulder J, Krediet RT: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis [Abstract]. J Am Soc Nephrol 8: 268A-269A, 1997
36. Douma CE, de Waart DR, Struijk DG, Krediet RT: Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? J Lab Clin Med 132: 329-340, 1998
37. Breborowicz A, Wieczorowska-Tobis K, Korybalska K, Polubinska A, Radkowski M, Oreopoulos DG: The effect of a nitric oxide inhibitor (L-NAME) on peritoneal transport during dialysis in rats. Perit Dial Int 18: 188-192, 1998
38. Stamler JS: Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994
39. Goffin E, Combet S, Jamar F, Cosyns J-P, Devuyst O: Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 33: 383-388, 1999
40. Topley N: Membrane longevity in peritoneal dialysis: Impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 5: 179-184, 1998
41. Barna M, Komatsu T, Reiss CS: Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223: 331-343, 1996
42. Xue C, Reynolds PR, Johns RA: Developmental expression of NOS isoforms in fetal rat lung: Implications for transitional circulation and pulmonary angiogenesis. Am J Physiol 14: L88-L100, 1996
43. Ziche M, Morbidelli L, Choudhuri R, Zhang H-T, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997
44. Korbet SM, Makita Z, Firanek CA, Vlassara H: Advanced glycosylation end-products in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 22: 588-591, 1993
45. Dawnay AB: Advanced glycation end-products in peritoneal dialysis. Perit Dial Int 16: S50-S53, 1996
46. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katok N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S: Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51: 182-186, 1997
47. Bucala R, Vlassara H: Advanced glycosylation end-products in diabetic renal and vascular disease. Am J Kidney Dis 26: 875-888, 1995
48. Thomas KA: Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271: 603-606, 1996